Seropram (Citalopram)

Quick links

Choose a section

Quick links to important sections

Advertisements

Seropram (Citalopram)

Advertisements
Advertisements

Treatment option: Depression, Neurosis

Advertisements

Overview of Seropram (Citalopram)

What is Seropram (Citalopram) and What is it Made Of?

Seropram, which utilizes the generic compound Citalopram, is a prescription medication based on the single active substance, Citalopram Hydrobromide. This compound is a synthetic organic compound originating as a racemic bicyclic phthalane derivative. The medication is available in dual oral dosage forms, including film-coated tablets and a bioequivalent oral solution (liquid drops). As a single-active ingredient product, Citalopram Hydrobromide is the sole pharmacologically active component, formulated alongside inert excipients to facilitate reliable oral administration and absorption into the body.

What Type of Medicine is Seropram (Citalopram)?

Citalopram is an antidepressant that belongs specifically to the class of Selective Serotonin Reuptake Inhibitors (SSRIs). This classification reflects the precise mechanism by which the substance acts within the central nervous system (CNS). The drug’s action involves the selective inhibition of serotonin reuptake at the neuronal membrane. This selectivity is a key feature of Citalopram, as it exhibits minimal affinity for the transport mechanisms of other key monoamine neurotransmitters. Consequently, the drug’s primary function remains focused on enhancing serotonergic activity.

What is the General Purpose of Seropram?

The general purpose of Citalopram is to support the sustained improvement of emotional function and mood by correcting chemical imbalances in the brain. The medication is used for relieving states of persistent low mood and emotional instability. It is designed to provide consistent, daily support for the brain's internal mechanisms that govern emotional balance. It is widely recognized as an essential medicine, confirming its established role in pharmaceutical treatment globally.

Regulatory References

  1. WHO Model List of Essential Medicines
Advertisements

What side effects are possible with Seropram (Citalopram)?

Possible Side Effects and Safety Information

Seropram (Citalopram) carries important safety information related to its use. The most significant concern is a dose-dependent risk of QT interval prolongation, an electrical change in the heart that can lead to life-threatening abnormal heart rhythms (Torsade de Pointes). Due to this risk, the maximum recommended daily dose for most adults is 40 mg, and the maximum is further restricted to 20 mg per day for patients over 60 years of age, those with hepatic impairment, or those who are CYP2C19 poor metabolizers.

Officially documented warnings also include an increased risk of suicidal thoughts and behavior in children, adolescents, and young adults (up to age 24) compared to placebo. All patients should be closely monitored for clinical worsening and unusual behavioral changes when therapy is initiated or when the dosage is adjusted.

Common adverse reactions often involve the Central Nervous System and Gastrointestinal systems, including nausea, dry mouth, insomnia, somnolence, increased sweating, and ejaculation disorder (primarily ejaculation delay).

Other serious or clinically significant risks documented in regulatory labeling include:

  • Serotonin Syndrome, especially when taken with other serotonergic drugs or MAOIs (Monoamine Oxidase Inhibitors).
  • Abnormal Bleeding/Hemorrhage, with increased risk when co-administered with NSAIDs, aspirin, or anticoagulants.
  • Hyponatremia (low sodium), which is a greater concern in elderly patients.
  • Activation of Mania/Hypomania in patients with or at risk for Bipolar Disorder.
  • Angle-Closure Glaucoma (risk to the eye).

Citalopram is contraindicated for use with MAOIs and with certain drugs known to prolong the QT interval (e.g., pimozide). Safety is not established for the pediatric population. Abrupt discontinuation should be avoided due to the potential for a discontinuation syndrome.

Advertisements

Overdose and Emergency Response

Documented Overdose Manifestations and Severe Risks

The official regulatory documents describe Citalopram overdose manifestations across several physiological systems. Documented signs include central nervous system effects such as dizziness, somnolence, agitation, tremor, and seizures, which may escalate to coma. Gastrointestinal effects such as nausea and vomiting are also commonly reported. The most serious documented outcome is cardiac toxicity, which includes QT interval prolongation, leading to potentially fatal events like Torsade de Pointes (TdP), ventricular arrhythmia, and cardiac arrest. Individuals aged over 60 or those with hepatic impairment are identified in labeling as having an increased risk for these severe cardiac outcomes.

Required Emergency Actions and Management

In the event of a suspected overdose, regulatory guidance mandates that patients seek immediate medical attention. Emergency services must be contacted immediately if the affected person has collapsed, experiences a seizure, has trouble breathing, or cannot be awakened (unconsciousness). Treatment for citalopram overdose is defined as symptomatic and supportive only, as official labeling confirms that no specific antidote is known. Hospital monitoring, including continuous ECG monitoring and assessment of electrolytes, is typically required until the patient is clinically stable.

Advertisements

Therapeutic Uses of Seropram (Citalopram)

Citalopram is commonly used to help manage Major Depressive Disorder and may assist with symptoms related to Panic Disorder and certain anxiety conditions. The medication is often used to help manage symptoms related to low mood (depression). This medication is generally applied in clinical settings marked by heightened patient distress, where supportive symptom management is appropriate.

The core therapeutic domains include helping to ease the pervasive feelings of sadness, emotional emptiness, and hopelessness associated with depression, as well as assisting in the management of the sudden onset of fear in panic attacks. Furthermore, it plays a role in managing the recurrence of these episodic manifestations for long-term well-being.

“The primary goal is to provide supportive relief when symptoms interfere with routine activities, which may help patients cope more steadily.”

This provides support that helps ease the overall symptom burden, assisting with maintaining functional stability. The medicine is commonly used in situations involving recurrent or episodic manifestations, applied during phases when symptoms become more noticeable.


Quick Fact: Relief for Anhedonia and Low Energy The medicine is commonly used to help manage symptoms that interfere with daily functioning, such as the loss of interest or pleasure (anhedonia) and low energy, which may assist with maintaining functional stability.

Advertisements

Eligibility and Restrictions for Use

Seropram (Citalopram) is approved for use in adults but is subject to several strict exclusions and limitations based on official regulatory documentation from agencies like the FDA and EMA.

Populations Who Must Not Use Citalopram (Contraindications)

  • Monoamine Oxidase Inhibitors (MAOIs): Citalopram is contraindicated if a patient is currently taking, or has stopped within the last 14 days, an MAOI, including drugs like linezolid or intravenous methylene blue.
  • Pimozide: Concomitant use with pimozide is contraindicated due to the risk of QT prolongation, a serious heart rhythm abnormality.
  • Hypersensitivity: Individuals with a known allergy or hypersensitivity to citalopram or its ingredients should not use the medicine.

Populations with Eligibility Restrictions

Population Category Eligibility Status Basis for Restriction
Pediatric Patients (<18 years) Not Approved Safety and efficacy are not established.
Older Adults (>60 or >65 years) Restricted Use Maximum recommended daily dose is 20 mg due to increased drug exposure and QT prolongation risk.
Hepatic Impairment Restricted Use Maximum recommended daily dose is 20 mg due to reduced clearance.
Cardiac Risk Factors Use Not Recommended Not recommended for patients with congenital long QT syndrome or those with risk factors like bradycardia, hypokalemia, or recent heart attack.
Pregnancy Conditional Use Use in late pregnancy carries a risk of conditions like Persistent Pulmonary Hypertension of the Newborn (PPHN) in the infant.

Eligibility is also conditional for patients with conditions like untreated anatomically narrow angles (glaucoma risk) or a history of seizures or bipolar disorder.

Advertisements

What should I know about interactions with other medicines?

Seropram (Citalopram) Interactions with other medicines and products

Citalopram (Seropram) can interact with a wide range of medications, increasing the risk of serious side effects. It is essential to inform your healthcare provider about all prescription, over-the-counter drugs, and herbal supplements you are taking.


Contraindicated Combinations

Avoid co-administration with Monoamine Oxidase Inhibitors (MAOIs), including linezolid and methylene blue injection, due to the high risk of serotonin syndrome, a potentially life-threatening condition. A washout period of at least 14 days is required when switching between Citalopram and an MAOI.

Citalopram should also not be used with certain medications that significantly prolong the QT interval, such as pimozide, due to the risk of dangerous heart rhythm abnormalities (Torsade de Pointes).


Other Significant Interactions

Combining Citalopram with other serotonergic agents (e.g., triptans, other SSRIs, SNRIs, tramadol, or St. John's wort) can increase the risk of serotonin syndrome.

Citalopram may increase the risk of bleeding or bruising. Use caution when co-administered with Nonsteroidal Anti-inflammatory Drugs (NSAIDs), aspirin, or anticoagulants/antiplatelet agents (e.g., warfarin, clopidogrel). Certain drugs that inhibit CYP enzymes (e.g., cimetidine, omeprazole) can increase Citalopram levels. Alcohol should be avoided as it can worsen central nervous system side effects.

Advertisements

Mechanism of Action

How Seropram (Citalopram) Works

Citalopram functions as a selective serotonin reuptake inhibitor (SSRI), exerting its primary action within the central nervous system (CNS).

Its mechanism centers on the serotonin transporter (SERT) protein located on presynaptic neurons. Citalopram binds to and inhibits the reuptake function of SERT, which prevents the active transport of serotonin (5-HT) from the synaptic cleft back into the neuron. This molecular interaction results in an increased extracellular concentration of 5-HT within the synapse.

The heightened presence of 5-HT leads to enhanced engagement with various postsynaptic serotonin receptors, thereby modifying receptor-mediated signaling. This cascade of events initiates a gradual, sustained change in overall neuronal activity and feedback regulation within the affected neurochemical pathways. This sustained modulation contributes to predictable physiological adjustments and influences the activity profile of the targeted neural circuits.

Advertisements

Dosage and Administration Information

Administration Guidelines

Citalopram is administered exclusively via the oral route and is available as film-coated tablets (in strengths up to 40 mg) and as an oral solution. The medicine is taken once daily and may be administered either with or without food, allowing flexibility in daily scheduling. For the liquid formulation, the solution is to be mixed with fluids such as water or juice before immediate consumption.


Standard Dosing and Adjustment

The established starting dose for the general adult population is 20 mg once daily. Dose adjustments, if deemed necessary by a clinician, should be made at intervals of no less than one week. The maximum recommended daily amount for the general adult population is 40 mg.

Dose Restrictions (Maximum 20 mg Daily)

Patient Group Basis for Restriction
Individuals >60 years of age Restricted due to age-related exposure changes
Individuals with Hepatic Impairment Restricted due to reduced clearance
Known CYP2C19 poor metabolizers Restricted due to increased exposure levels

Procedural Course and Cessation

Therapy generally involves a sustained course, continuing for several months after symptomatic improvement is achieved. If a dose is missed, the standard procedure is to skip the missed dose and resume the regular schedule, without taking two doses to compensate. When discontinuing the medicine, the dose must always be gradually reduced (tapered) over a period of time to follow established procedural steps.

Advertisements

Recent Clinical Evidence

Seropram (Citalopram): Recent Clinical Evidence

Therapeutic Role and Mechanism

Citalopram is classified as a Selective Serotonin Reuptake Inhibitor (SSRI). Its FDA-approved indication is for the treatment of Major Depressive Disorder (MDD) in adults. The drug is presumed to influence mood regulation by potentiating serotonergic activity in the central nervous system (CNS). Studies suggest this occurs through the inhibition of CNS neuronal reuptake of serotonin (5-HT), leading to an increased concentration of serotonin in the synaptic cleft.

Clinical Efficacy and Outcomes

Clinical trials, including randomized, placebo-controlled studies, established Citalopram's effectiveness in managing the symptoms of MDD over treatment periods typically ranging from four to six weeks. Longer-term maintenance trials indicate that Citalopram, similar to other antidepressants, helps delay the recurrence of depressive episodes in adults. While Citalopram is primarily indicated for depression, research has also explored its use in other conditions such as Generalized Anxiety Disorder (GAD) and Obsessive-Compulsive Disorder (OCD), which are considered off-label uses.

Safety and Tolerability Profile

Citalopram is generally considered to be a highly selective SSRI, binding with minimal affinity to most other receptors (e.g., histamine, muscarinic cholinergic). This selectivity is thought to contribute to a relatively favorable adverse effect profile compared to older classes of antidepressants. However, Citalopram is known to cause a dose-dependent QTc interval prolongation, a change in the heart's electrical activity. Due to this risk, the FDA has issued warnings and revised dosing recommendations, limiting the maximum recommended dose for adults to 40 mg per day. A lower maximum dose of 20 mg per day is recommended for patients over 60 years of age and those with hepatic impairment.

Key Studies & References Citalopram - StatPearls - NCBI Bookshelf

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Seropram (Citalopram) (FAQ)

Q: How quickly should I expect to feel an effect from Citalopram?

Official documents indicate that the effect of the medicine is gradual. While some patients may notice an initial improvement in symptoms after about one week of starting treatment, the full change in symptoms may typically become evident between the second and fourth week of continuous therapy.


Q: Can Citalopram be taken by individuals who also use nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen?

Official warnings state that using Citalopram with NSAIDs, such as ibuprofen or aspirin, requires caution. This combination may increase the risk of bleeding or bruising.


Q: What are the potential effects of Citalopram on sex drive or sexual function?

The official product labeling documents that changes in sexual function are common side effects. These reactions can include a decreased sex drive (libido) and other forms of sexual dysfunction, such as ejaculation delay in males and difficulty achieving orgasm.


Q: Can Citalopram cause increased sweating or hot flashes?

Official regulatory documents list increased sweating (hyperhidrosis) as a commonly reported adverse reaction. Hot flashes are not typically listed as a distinct, common side effect in the core regulatory labeling.


Q: Does Citalopram have an effect on energy levels or cause tiredness/fatigue?

Yes, official documents note that Citalopram can potentially affect energy and sleep. Regulatory documents list both somnolence (drowsiness or sleepiness) and fatigue as possible adverse reactions.


Q: What is the guidance on Citalopram use for patients with bipolar disorder or a history of mania?

Regulatory documents state that Citalopram should be used with caution in patients who have a history of mania or bipolar disorder due to the potential risk of activating a manic or hypomanic episode.


Q: How does Citalopram affect individuals who are poor metabolizers of the CYP2C19 enzyme?

Individuals identified as CYP2C19 poor metabolizers process the drug more slowly, resulting in increased levels of Citalopram in the body. Because of this, regulatory guidance restricts the maximum daily dose to 20 mg for this population to mitigate the risk of heart rhythm changes.


Q: Is it common to feel worse or have increased anxiety when first starting Citalopram?

Official guidance on use for panic disorder notes that a low initial starting dose is recommended. This recommendation exists because an initial worsening of panic symptoms is generally recognized to occur early in the treatment of this type of disorder.


Q: How long does Citalopram typically stay in the body after a dose?

According to official pharmacokinetics information, the elimination half-life of Citalopram is approximately 35 hours for the general adult population.


Q: What is the difference between Citalopram and Escitalopram (Lexapro)?

Citalopram is a mixture of two mirror-image molecules (called a racemate), while Escitalopram contains only one of those molecules (the S-enantiomer). Both are SSRIs, but they have different FDA-approved uses and dose restrictions.


Q: Is Citalopram known to cause changes in weight, either gain or loss?

Regulatory documents list changes in weight as possible adverse reactions. Official prescribing information documents reports of both weight increase and weight decrease as side effects.


Q: Is there a risk of developing heart rhythm problems (QT prolongation) with Citalopram?

Yes. Official regulatory warnings note that Citalopram can cause dose-dependent QT interval prolongation, an electrical change in the heart that may lead to serious, abnormal heart rhythms such as Torsade de Pointes.


Q: Are there any known issues with Citalopram use during pregnancy?

Official documents state that use in late pregnancy (the third trimester) may be associated with conditions in the infant, such as Persistent Pulmonary Hypertension of the Newborn (PPHN). An increased risk of postpartum hemorrhage for the mother has also been observed.


Q: Is Citalopram excreted into breast milk, and what is the official advice on breastfeeding?

Citalopram is excreted into human breast milk. Official documents state that a decision should be made in conjunction with a clinician whether to discontinue breastfeeding or discontinue the medicine, taking into account the drug's importance to the mother.


Q: Can Citalopram affect a person's ability to drive or operate machinery?

Official warnings state that Citalopram may cause reactions like visual disturbance, dizziness, or nausea. Individuals should be cautious when driving or operating machinery until they are reasonably certain the medicine does not negatively affect their abilities.


Q: Is it common to experience vivid dreams or changes in dream patterns while on Citalopram?

Official labeling for the related SSRI, Escitalopram, has been associated with reports of abnormal dreaming or changes in dream content in clinical trials. This is informational evidence related to the drug class.


Q: Does Citalopram affect blood sugar levels for individuals with diabetes?

Official patient resources indicate that Citalopram may make it more difficult to maintain stable blood sugar levels in individuals with diabetes. For this reason, closer monitoring of blood sugar levels may be necessary when treatment is initiated.


Q: How long is a typical course of treatment with Citalopram for depression or anxiety?

Official guidance states that for depression, treatment should continue for a sustained period, typically a minimum of 6 months after symptoms are relieved to help prevent recurrence. For conditions like panic disorder, the treatment period may be several months or longer.


Q: What official guidelines exist for monitoring patients when Citalopram treatment is started?

Official guidelines recommend close monitoring for clinical worsening and unusual behavioral changes, particularly the emergence of suicidal thoughts. For patients with heart risk factors, guidelines require that the QT interval (via an ECG) be monitored.


Q: Can a person experience 'brain zaps' or electric shock sensations when discontinuing Citalopram?

Official documentation on discontinuation syndrome lists electric shock-like sensations as a sensory disturbance that may be reported by patients during the process of stopping the medicine.


Q: Can Citalopram cause tremors or restlessness (akathisia)?

Yes, official prescribing information lists both tremor (shaking) and akathisia (a state of inner restlessness that can lead to constant movement) as documented adverse reactions.


Q: What are the common behavioral changes to watch for in young adults starting Citalopram?

Regulatory warnings for young adults (up to age 24) require monitoring for the emergence of behavioral changes, including agitation, irritability, hostility, and suicidal thoughts and behavior, when therapy is initiated or doses are adjusted.


Q: Does taking Citalopram at a certain time of day (morning vs. evening) affect side effects like sleepiness?

Official prescribing information states the medicine can be taken once daily in the morning or evening with or without food. This choice is usually made based on patient preference and how the medicine affects their sleep or wakefulness.


Q: Is it possible for the side effects of Citalopram to continue after the medicine is stopped?

Official documents indicate that while symptoms typically resolve within days or weeks, they may persist for several weeks or longer in some cases.


Q: Does Citalopram have any known effects on appetite?

Yes, official regulatory documents list changes in appetite as potential side effects. Specifically, both decreased appetite and loss of appetite are documented in the prescribing information.


Q: Does Citalopram interact with caffeine?

Official regulatory labels do not contain a specific contraindication or warning regarding a direct drug interaction between Citalopram and caffeine.


Q: Does Citalopram interact with common over-the-counter pain relievers like paracetamol/acetaminophen?

Official drug interaction checkers and prescribing information do not report a known interaction between Citalopram and the common pain reliever paracetamol (acetaminophen).

Advertisements

How should Seropram (Citalopram) be stored and disposed of?

Storage and Disposal of Seropram (Citalopram)

Citalopram tablets must be stored at controlled room temperature, specifically between 20^circ and 25 C (68^circ to 77 F), and should be kept away from excess heat and moisture. The medication must remain in the original container, which should be tightly closed.


Child Safety and Stability

All forms of Citalopram must be stored strictly out of the reach of children. For the oral solution, once opened, any unused portion must be discarded after 30 days.


Disposal Protocols

The preferred method for disposing of unused or expired Citalopram is through a drug take-back program. If this is unavailable, the medicine can be mixed with an undesirable substance (like dirt or used coffee grounds), sealed, and disposed of in the household trash. Citalopram is not recommended for disposal by flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Seropram (Citalopram) found in:

A-Z Index: